A recent analysis prepared on behalf of America’s Health Insurance Plans (AHIP) indicates that drug rebates have not been the primary driver of rising drug prices—as some advocates have claimed.
AHIP: Rebates not driving rise in drug pricing
A recent analysis prepared on behalf of America’s Health Insurance Plans (AHIP) indicates that drug rebates have not been the primary driver of rising drug prices—as some advocates have claimed.